Austria: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
WeeksMonthsYears
6234569101112142357910111214151718305960≥ 61
RSV
RSV1
Coronavirus disease (COVID-19)
COVID-192
rotavirus infection
ROTA3
diphtheria
D4
D5
D6
d7
d8
d9
tetanus
TT4
TT5
TT6
TT7
TT8
TT9
pertussis
acP4
acP5
acP6
acP7
acp8
acp10
poliomyelitis
IPV4
IPV5
IPV6
IPV7
IPV8
Haemophilus influenzae type b infection
Hib4
Hib5
Hib6
hepatitis B
HepB4
HepB5
HepB6
HepB11
pneumococcal disease
PCV1512
PCV15
PCV15
PCV2113
PCV2113
meningococcal disease
MenB14
MenB
MCV4/MenB
MCV4
measles
MEAS15
MEAS
mumps
MUMPS15
MUMPS
rubella
RUBE15
RUBE
varicella
VAR16
VAR
human papillomavirus infection
HPV9 (F/M)
HPV9 (F/M)17
influenza
IIV3/LAIV
IIV3
aIIV3 / IIV3-HD 18
herpes zoster
ZOS19
ZOS19
tick-borne encephalitis
TBE20

Version:


Footnotes:

  1. More information: https://impfen.gv.at/impfungen/rsv or https://www.sozialministerium.gv.at/impfplan (p. 110ff)
  2. The COVID-19 vaccination is recommended for everyone aged 12 and over who wishes to reduce their risk of severe disease. Preferably in autumn, a single dose is recommended with descending priority for: [a] People with specific indications (e.g. individuals with underlying medical conditions) and all people aged 60 and above; [b] Healthcare professionals
  3. Two or three doses depending on the vaccine used (3rd dose only for pentavalent rotavirus vaccines). Vaccination is recommended for infants from the age of 6 weeks and, depending on the vaccine, should be completed by the age of 24 weeks (monovalent rotavirus vaccine) or 32 weeks (pentavalent rotavirus vaccine) at the latest. More information: https://www.sozialministerium.gv.at/impfplan (p. 117ff)
  4. Primary immunisation with a hexavalent vaccine as soon as possible after the age of 6 weeks (in any case by 3 months of age)
  5. Second dose of a hexavalent vaccine should be given 2 months after the first dose
  6. The third dose of the hexavalent vaccine should be given 6 months after the second dose, at the age of 10–12 months
  7. The first booster dose with a tetravalent dTaP-IPV vaccine recommended at the age of 5 years
  8. The second booster of the tetravalent dTaP-IPV vaccine is recommended 5 years after the first booster, or latest between 13/14 years of age
  9. After 15 years of age, booster vaccinations recommended with a dTaP vaccine every 5 years. If there is no special indication for further polio vaccinations and two or more booster vaccinations against polio (with IPV) have been given after the basic immunisation, only diphtheria-tetanus-pertussis vaccinations are then given.
  10. After 15 years of age, booster vaccinations recommended with a dTaP vaccine every 5 years. Vaccination of pregnant women recommended but not funded, preferably in the 3rd trimester (27th-36th week of pregnancy), independent from the interval to the last vaccination against pertussis.
  11. After primary immunisation, one booster dose is recommended between the ages of 7 and 15. After that, further booster doses are only recommended for people with specific indications. If primary immunisation was not carried out in infancy, it should be done at the earliest opportunity. Hepatitis B vaccination can be caught up at any age and is recommended up to the age of 60. In special cases, primary immunsiation is also possible after the age of 60. More information: https://www.sozialministerium.gv.at/impfplan (p. 35ff)
  12. Vaccination with PCV15 as soon as possible after the age of 6 weeks, and no later than the age of 3 months. Second dose is given 8 weeks after the first dose, and third dose at the age of 11–15 months (at the earliest 6 months after the second dose). For children without specific indications, vaccination is not recommended after the age of 5. More information: https://impfen.gv.at/impfungen/pneumokokken or https://www.sozialministerium.gv.at/impfplan (p. 93ff)
  13. Vaccination recommended and free of charge for people aged 60 and over and for certain high-risk individuals aged 18 and over. Persons aged 60 years and older who have previously been vaccinated with another pneumococcal vaccine should receive a single dose of PCV21 after approximately 1 year for broader serotype coverage. Even if they have previously been vaccinated sequentially (PCV13/PCV15/PCV20 followed by PPV23), a single booster dose of PCV21 should be given, with the recommended interval being at least 1 year (for PCV13/15 followed by PPV23) and no more than 6 years (PCV20 followed by PPV23) after the last dose. More information: https://www.sozialministerium.gv.at/impfplan (p. 95ff)
  14. MenB vaccination is recommended as early as possible from the age of 2 months and not funded. Catch-up vaccinations are recommended up to the age of 25. MenACWY vaccination is recommended as early as possible at the age of 13 months and not funded. One dose of the tetravalent conjugated meningococcal vaccine is recommended between the ages of 10-13 and funded. Additionally, please refer to official recommendations for timing and number of doses required according to age: https://www.sozialministerium.gv.at/impfplan (p. 77ff)
  15. If the first dose is given in the first year of life, the recommended interval between the doses is 3 months (minimal interval 4 weeks). If the first dose of MMR is given after the first birthday, the second dose is recommended as early as possible with a minimal interval of 4 weeks.
  16. Vaccination is recommended from the age of 1 year. Further, the vaccination is recommended for all non-immune adults up to the age of 60. Two doses with an interval of 6 weeks. More information: https://www.sozialministerium.gv.at/impfplan (p. 124ff)
  17. Catch-up recommendation up to the age of 30. A 2 doses regimen is recommended from 9 to 30 years of age, from 30 onwards, a 3 doses regimen. Free of charge from 9 to 21 years of age. With a temporary catch-up vaccination programme, people aged between 21 and 30 can receive the vaccination free of charge from 1 July 2024. The following applies: the first dose could be given free of charge until 31 December 2025, so that the second dose could also be given free of charge until 30 June 2026. More information: https://impfen.gv.at/impfungen/hpv or https://www.sozialministerium.gv.at/impfplan (p. 45ff)
  18. For all >60 years old, aIIV3 (funded) and IIV3-HD (not funded) is recommended. More information: https://impfen.gv.at/impfungen/influenza or https://www.sozialministerium.gv.at/impfplan (p. 54ff)
  19. Zoster vaccination refunded for certain high-risk individuals aged 18 and over. Free of charge for people aged 60 and over.
  20. Primary immunisation with 3 doses (0/1-3month/5-12 or 9-12 months depending on vaccine used). First booster 3 years after primary immunisation and afterwards additional booster doses every 5 years up to the age of 60. 60 years and above booster doses every 3 years. More information: https://www.sozialministerium.gv.at/impfplan (p. 25ff)


More information available at:
https://www.sozialministerium.gv.at/Themen/Gesundheit/Impfen/impfplan.html


--------------------------------------------------------------------------------
For a full details on catch-up vaccination and additional information please refer to the 2026 National Immunisation Schedule for Austria
https://www.sozialministerium.gv.at/Themen/Gesundheit/Impfen/impfplan.html

--------------------------------------------------------------------------------

Date of last update: 29 January 2026

--------------------------------------------------------------------------------